Physician and Pharmacist Liability: Medicolegal Cases That are Tough Pills to Swallow

Schupbach, John C.S.; Kaisler, Maria C.; Moore, Gregory P.; Sandefur, Benjamin J.

doi:10.5811/cpcem.2021.4.51851

Cited by 2 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are several possible patient scenarios, of varying plausibility, out of which a malpractice suit might arise 15,16,17 : (1) patients who allege that they were inadequately treated because of an antibiotic or lack thereof, (2) patients who allege that they suffered harmful side effects because of an antibiotic, and (3) patients who allege that they suffered an infection from a resistant organism that would have otherwise been preventable but for insufficient antibiotic stewardship.…”

Section: Stewardship and Sources Of Liabilitymentioning

confidence: 99%

How Might Antibiotic Stewardship Programs Influence Clinicians’ Autonomy and Organizations’ Liability?

2024

AMA Journal of Ethics

View full text Add to dashboard Cite

Federal and state governments mandate some health care organizations to implement antibiotic stewardship programs (ASPs). Some early adopters developed model ASPs that have helped set industry standards; other benchmarks will likely be forged in subsequent regulation, legislation, and jurisprudence. This article considers how ASP designs can affect professional autonomy, especially of frontline antibiotic stewards who are usually physicians and pharmacists. This article also considers how ASP development and implementation might influence standards of care and malpractice liability.

show abstract

Section: Stewardship and Sources Of Liabilitymentioning

confidence: 99%

How Might Antibiotic Stewardship Programs Influence Clinicians’ Autonomy and Organizations’ Liability?

2024

AMA Journal of Ethics

View full text Add to dashboard Cite

show abstract

“…Some providers or prescribers also perceived MOUD as replacing one substance with another substance and, as a result, believed the better treatment of OUD was abstinence as compared with MOUD [ 10 , 13 ]. Additionally, fear of possible lawsuits due to inappropriate prescriptions could also be a reason for their reluctance [ 14 , 15 ]. Inappropriate prescriptions have affected the physical and mental health of Americans and have led to many lawsuits against many healthcare facilities and providers [ 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

“…Additionally, fear of possible lawsuits due to inappropriate prescriptions could also be a reason for their reluctance [ 14 , 15 ]. Inappropriate prescriptions have affected the physical and mental health of Americans and have led to many lawsuits against many healthcare facilities and providers [ 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

Association between Prescribers’ Perceptions of the Utilization of Medication for Opioid Use Disorder and Opioid Dependence Treatability

et al. 2022

View full text Add to dashboard Cite

Background: Medication for opioid use disorder (MOUD) has been proven to be effective, yet the perceptions or beliefs of prescribers of MOUD may have a substantial impact on their prescribing and dispensing of MOUD and their patients’ accessibility and utilization of MOUD services. We examined the associations of the perceptions of medical and pharmacy professionals regarding MOUD with sociodemographic characteristics, personal experiences with substance use disorders, and perceptions of opioid treatment. Method: Data were collected via telephone or online survey from March to August 2021, in Texas, to assess medical and pharmacy professionals’ perceptions of MOUD. Our sample included 542 participants who completed the survey. A multinomial logistic regression analysis was conducted to assess perceptions of MOUD, its use, and their correlates. Results: The participants had a mean age of 35 years (SD = 7.13) and had worked, on average, 6.90 years (SD = 5.37) in their current positions. The majority of the participants were males (50.93%) and medical professionals (82.01%). More than one third of the participants believed MOUD did not lead to abstinence or recovery (36.16%). Those who had personal experiences with a substance use disorder were more likely to believe that MOUD could be a replacement drug for previously misused substance(s) (RRR = 2.06, 95% CI = 1.19, 3.59) and that MOUD did not lead to abstinence or recovery (RRR = 2.34, 95% CI = 1.40, 3.91). However, the risk ratio values were lower for those who believed that a stigma against MOUD was a barrier for patients initiating and adhering to MOUD (MOUD is a replacement drug for previously misused substances (initiation RRR = 0.43, 95% CI = 0.19, 0.93 and adhering RRR = 0.30, 95% CI = 0.13, 0.71) or MOUD does not lead to abstinence or recovery (initiation RRR = 0.26, 95% CI = 0.13, 0.54 and adhering RRR = 0.36, 95% CI = 0.17, 0.78)). The various perceptions of the utilization of MOUD were not statistically different between medical and pharmacy professionals. Conclusion: Perceptions, experience with substance use disorder, and stigma against the utilization of MOUD influenced negative perceptions about MOUD. An innovative strategy is needed to improve medical and pharmacy professionals’ perceptions of MOUD, while efforts are being made to promote the use of MOUD for patients with opioid use disorders.

show abstract

Physician and Pharmacist Liability: Medicolegal Cases That are Tough Pills to Swallow

Cited by 2 publications

References 5 publications

How Might Antibiotic Stewardship Programs Influence Clinicians’ Autonomy and Organizations’ Liability?

How Might Antibiotic Stewardship Programs Influence Clinicians’ Autonomy and Organizations’ Liability?

Association between Prescribers’ Perceptions of the Utilization of Medication for Opioid Use Disorder and Opioid Dependence Treatability

Contact Info

Product

Resources

About